Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Digicann Ventures Inc. (CSE: DCNN.X) ("Digicann" or the "Company"), is a reporting issuer listed on the Canadian Securities Exchange (the "CSE"). The Company is currently focused on ident

$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if war

Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type 1 and type 2 diabetesNew data and real-world findings further emphasize pediatric safety, glycemic control and treatment sat

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a once-weekly injection and a once-daily oral pill for the treatment of obesity and overweightAdditional data from Phase 2 obesity clinic

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 recepto

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - South Pacific Metals Corp. (TSXV: SPMC) (OTCQB: SPMEF) (FSE: 6J00) ("SPMC" or "South Pacific Metals" or the "Company") announces that it has entered into an online marketing agreement dat

Toronto, Ontario--(Newsfile Corp. - June 5, 2026) - Street Capital Inc. (the "Company") announces that, effective May 28, 2026, Tabitha Fritz has resigned from her position as a member of the Company's Board of Directors and Audit Committee. The Comp

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Custom Health Holdings Inc. (formerly, Queue Ventures Ltd.) ("Custom Health" or the "Company"), further to its press release dated May 13, 2026, is pleased to announce the successful comp

Mr. Stanley to dedicate his full attention to advancing DeFloria's FDA Phase 2 botanical drug program, a Charlotte's Web-affiliated clinical-stage ventureLouisville, Colorado--(Newsfile Corp. - June 5, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWE

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - District Metals Corp. (TSXV: DMX) (Nasdaq First North: DMXSE SDB) (OTCQX: DMXCF) (FSE: DFPP); ("District" or the"Company") announces that it has granted a total of 2,820,000 incentive sto